Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-01-26

FDA Approved: VIGABATRIN FOR ORAL SOLUTION — Original Application (Camber Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved Vigabatrin for oral solution from Camber Pharmaceuticals as an original application, enabling a generic product for specified epilepsy-related indi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Vigabatrin for oral solution (Vigabatrin)

Snippet

ORIG AP for VIGABATRIN FOR ORAL SOLUTION (VIGABATRIN)